We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$14.8B
AUM Growth
+$2.92B
Cap. Flow
+$3.28B
Cap. Flow %
22.14%
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$217M
2
AAPL icon
Apple
AAPL
+$208M
3
MSFT icon
Microsoft
MSFT
+$199M
4
AMZN icon
Amazon
AMZN
+$136M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$133M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$125M
2
GILD icon
Gilead Sciences
GILD
+$107M
3
PR
Permian Resources
PR
+$85.4M
4
RDDT icon
Reddit
RDDT
+$84.1M
5
KEYS icon
Keysight
KEYS
+$79M

Sector Composition

Rank Sector Weight
1 Healthcare 31.96%
2 Technology 25.64%
3 Financials 7.58%
4 Industrials 6.88%
5 Communication Services 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOMA
526
DELISTED
Xoma
XOMA
$4.11M 0.03%
156,266
+60,927
+64% +$1.78M
COF icon
527
Capital One
COF
$135B
$4.09M 0.03%
+22,911
New +$3.97M
CRSP icon
528
CRISPR Therapeutics
CRSP
$5.03B
$4M 0.03%
101,600
+1,600
+2% +$75.6K
CBRL icon
529
Cracker Barrel
CBRL
$1.32B
$3.99M 0.03%
+75,489
New +$3.73M
WMB icon
530
Williams Companies
WMB
$88B
$3.96M 0.03%
+73,207
New +$3.95M
DVA icon
531
DaVita
DVA
$11.5B
$3.92M 0.03%
26,190
-159,919
-86% -$25.1M
LEGN icon
532
Legend Biotech
LEGN
$3.71B
$3.91M 0.03%
120,304
+10,909
+10% +$452K
ONC
533
BeOne Medicines Ltd
ONC
$36.6B
$3.91M 0.03%
21,166
+4,318
+26% +$882K
KRRO icon
534
Korro Bio
KRRO
$169M
$3.89M 0.03%
+102,094
New +$5.25M
AVBP icon
535
ArriVent BioPharma
AVBP
$1.43B
$3.88M 0.03%
145,797
+24,853
+21% +$714K
APD icon
536
Air Products & Chemicals
APD
$66.5B
$3.87M 0.03%
+13,351
New +$4.19M
MAR icon
537
Marriott International
MAR
$93.8B
$3.86M 0.03%
+13,852
New +$3.8M
ADCT icon
538
ADC Therapeutics
ADCT
$144M
$3.85M 0.03%
+1,933,751
New +$5.06M
OS
539
DELISTED
OneStream Inc
OS
$3.82M 0.03%
133,900
+1,515
+1% +$46.5K
WOOF icon
540
Petco
WOOF
$785M
$3.82M 0.03%
1,002,204
-922,093
-48% -$4.17M
PLD icon
541
Prologis
PLD
$130B
$3.8M 0.03%
+35,948
New +$4.13M
IOT icon
542
Samsara
IOT
$21.9B
$3.78M 0.03%
+86,450
New +$4.25M
RDDT icon
543
Reddit
RDDT
$29.2B
$3.77M 0.03%
23,048
-680,932
-97% -$84.1M
IONS icon
544
Ionis Pharmaceuticals
IONS
$9.05B
$3.76M 0.03%
+107,610
New +$4.02M
CTAS icon
545
Cintas
CTAS
$80.5B
$3.76M 0.03%
+20,587
New +$4.33M
VKTX icon
546
Viking Therapeutics
VKTX
$3.88B
$3.75M 0.03%
93,294
+29,475
+46% +$1.68M
VSTM icon
547
Verastem
VSTM
$509M
$3.74M 0.03%
+723,806
New +$2.85M
RDNT icon
548
RadNet
RDNT
$5.29B
$3.74M 0.03%
53,556
-175,980
-77% -$13M
TGT icon
549
Target
TGT
$67B
$3.74M 0.03%
+27,665
New +$3.96M
EYPT icon
550
EyePoint Inc
EYPT
$1.07B
$3.74M 0.03%
501,724
+101,724
+25% +$947K

Similar funds

Woodline Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.

  • Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
  • Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
  • Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
  • Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
  • Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
  • Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
  • Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.

Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.